Shufro Rose & CO LLC P Lx Pharma Inc. Transaction History

Shufro Rose & CO LLC

  • $1.22 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 24, 2022
BUY
$0.52 - $3.08 $13,156 - $77,924
25,300 Added 44.54%
82,100 $53,000
Q2 2022

Jul 22, 2022
BUY
$1.9 - $4.18 $44,270 - $97,394
23,300 Added 69.55%
56,800 $138,000
Q1 2022

May 09, 2022
BUY
$3.54 - $8.3 $118,590 - $278,050
33,500 New
33,500 $135,000

Others Institutions Holding PLXP

# of Institutions
5
Shares Held
61.7K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Shufro Rose & CO LLC Portfolio

Follow Shufro Rose & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shufro Rose & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shufro Rose & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email